1-16 of 16
Juan Shen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nemtabrutinib Versus Ibrutinib or Acalabrutinib for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: The Phase 3, Open-Label, Randomized Bellwave-011 Study

Tamar Tadmor, Toby A. Eyre, Ohad Benjamini, Arvind Chaudhry, Juan Shen, Siyang Leng, Mohammed Z. H. Farooqui, David Lavie
Journal: Blood
Blood (2024) 144 (Supplement 1): 1875.2.
https://doi.org/10.1182/blood-2024-198731
Published: 2024
Journal Articles

Pembrolizumab in Children, Adolescents, and Young Adults with High-Risk Classic Hodgkin Lymphoma (cHL) with Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Christine Mauz-Koerholz, Luciana Vinti, Stephen Daw, Antony Ceraulo, Gerard Michel, Michaela Cepelova, Lorena Valero-Arrese, Franca Fagioli, Stéphane Ducassou, Salvatore Buffardi, Thierry Leblanc, Bradford S Hoppe, Frank G. Keller, Kara M. Kelly, Lisa Giulino Roth, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Rushdia Yusuf, Auke Beishuizen
Journal: Blood
Blood (2024) 144 (Supplement 1): 3055.
https://doi.org/10.1182/blood-2024-199675
Published: 2024
Journal Articles

Pembrolizumab in Children, Adolescents, and Young Adults with Low-Risk Classic Hodgkin Lymphoma (cHL) and Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Lisa Giulino Roth, Mario Melgar Toledo, Frank G. Keller, Bradford Hoppe, Christopher J. Forlenza, Sharon M. Castellino, Maitane Andión Catalan, Julie Krystal, Adam Lamble, Flavio Luisi, Fabio Molina Morales, Aarati V. Rao, Stacy Cooper, Oscar Gonzalez Llano, Luis Juarez Villegas, Christine Mauz-Koerholz, Juan Shen, Pallavi Pillai, Rushdia Yusuf, Kara M. Kelly
Journal: Blood
Blood (2024) 144 (Supplement 1): 462.
https://doi.org/10.1182/blood-2024-199263
Published: 2024
Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results from the Phase 2 Keynote-667 Study

Lisa Giulino Roth, Frank Keller, Mario Melgar Toledo, Sharon M. Castellino, Christopher J. Forlenza, Maitane Andión Catalan, Julie Krystal, Adam Lamble, Aarati V. Rao, Fabio Molina Morales, Stacy Cooper, Flavio Luisi, Oscar Gonzalez Llano, Karla Alejandra Lopez, Christine Mauz-Koerholz, Bradford Hoppe, Juan Shen, Pallavi Pillai, Patricia Marinello, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 1700.
https://doi.org/10.1182/blood-2023-186719
Published: 2023
Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Updated Results from the Phase 2 Keynote-667 Study

Christine Mauz-Koerholz, Auke Beishuizen, Luciana Vinti, Antony Ceraulo, Gerard Michel, Michaela Cepelova, Franca Fagioli, Constantino Sabado Alvarez, Stephane Ducassou, Salvatore Buffardi, Maitane Andión Catalan, Brad Hoppe, Frank Keller, Kara M. Kelly, Lisa Giulino Roth, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Stephen Daw
Journal: Blood
Blood (2023) 142 (Supplement 1): 3063.
https://doi.org/10.1182/blood-2023-187028
Published: 2023
Journal Articles

Fedratinib Induces Spleen Responses in Patients with Myeloproliferative Neoplasm-Associated Intermediate- or High-Risk Myelofibrosis (MF) Previously Exposed to Ruxolitinib (RUX), Regardless of Reason for Discontinuing RUX

Claire N Harrison, Professor, Nicolaas Schaap, MD PhD, Alessandro M Vannucchi, MD, Jean-Jacques Kiladjian, MD PhD, Eric Jourdan, MD, Richard T. Silver, MD, Harry C Schouten, MD PhD, Francesco Passamonti, MD, Sonja Zweegman, Moshe Talpaz, MD, Srdan Verstovsek, MD PhD, Shelonitda Rose, Juan Shen, PhD, Tymara Berry, MD, Carrie Brownstein, MD, Ruben A Mesa, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4165.
https://doi.org/10.1182/blood-2019-130069
Published: 2019
Journal Articles

A Novel Recurrent Chromosomal Inversion, Inversion(9)(p21q34), in Ph-Positive Leukemia Patients.

Jinlan Pan, Jun Zhang, Yongquan Xue, Yafang Wu, Juan Shen, Yong Wang, Dandan Liu, Suning Chen
Journal: Blood
Blood (2009) 114 (22): 4242.
https://doi.org/10.1182/blood.V114.22.4242.4242
Published: 2009
Journal Articles

Chromosome Study On Chronic Lymphocytic Leukemia Using CpG- Oligodeoxynucleotide as Immunostimulant Agent.

Yafang Wu, Yongquan Xue, Li Yao, Hui Jiang, Jun Zhang, Juan Shen, Jinlan Pan, Yong Wang, Shuxiao Bai, Suning Chen
Journal: Blood
Blood (2009) 114 (22): 4383.
https://doi.org/10.1182/blood.V114.22.4383.4383
Published: 2009
Journal Articles

Study On the Clonal Origin of Dysplastic Cells by Fluorescence in Situ Hybridization in Myelodysplastic Syndromes.

Jun Zhang, Yongquan Xue, Jinlan Pan, Yafang Wu, Juan Shen, Yong Wang, Dandan Liu, Suning Chen
Journal: Blood
Blood (2009) 114 (22): 4858.
https://doi.org/10.1182/blood.V114.22.4858.4858
Published: 2009
Journal Articles

Pulmonary Alveolar Proteinosis as a Terminal Complication in a Case of Myelodysplastic Syndrome with Idic(20q-).

Yongquan Xue, Yongsheng Han, Tianyu Li, Suning Chen, Jun Zhang, Jinlan Pan, Yafang Wu, Yong Wang, Juan Shen
Journal: Blood
Blood (2009) 114 (22): 4864.
https://doi.org/10.1182/blood.V114.22.4864.4864
Published: 2009
Journal Articles

Two Novel Translocations That Disrupt the RUNX1 Gene in Acute Myeloid Leukemia.

Haiping Dai, PhD, Yongquan Xue, PhD, Jinlan Pan, MM, Yafang Wu, MM, Yong Wang, MM, Juan Shen, Jun Zhang, MM
Journal: Blood
Blood (2007) 110 (11): 4127.
https://doi.org/10.1182/blood.V110.11.4127.4127
Published: 2007
Journal Articles

Clinical and Experimental Study in 21 Cases of Acute Leukemia with Trisomy 4.

Jin L. Pan, MD, Yong Q. Xue, MD, Hui Y. Qiu, PhD, Yong J. Zhu, PhD, Ya F. Wu, MD, Yong Wang, MD, Juan Shen, MD
Journal: Blood
Blood (2006) 108 (11): 4277.
https://doi.org/10.1182/blood.V108.11.4277.4277
Published: 2006
Journal Articles

Establishment and Characterization of a Human Acute Myelocytic Leukemic Cell Line, SH-2, Carrying t(16;17)(q24;q12).

Hui Y. Qiu, PhD, Yong Q. Xue, MD, Jin L. Pan, MD, Ya F. Wu, MD, Jun Zhang, MD, Yong Wang, MD, Juan Shen, MD, Ai P. Dai, PhD
Journal: Blood
Blood (2006) 108 (11): 4278.
https://doi.org/10.1182/blood.V108.11.4278.4278
Published: 2006
Journal Articles

A Novel Translocation (4;12)(q11;q13) in an Acute Promyelocytic Leukemia-Like Case Lacking RARα Rearrangements.

Hui Y. Qiu, PhD, Yong Q. Xue, MD, Jin L. Pan, MD, Ya F. Wu, MD, Yong Wang, MD, Juan Shen, MD, Jun Zhang, MD
Journal: Blood
Blood (2006) 108 (11): 4279.
https://doi.org/10.1182/blood.V108.11.4279.4279
Published: 2006
Journal Articles

Clinical and Interphase-FISH Studies of Deletion of Derivative Chromosome 9 in Patients with Chronic Myelogenous Leukemia.

Wei Wu, Yong-quan Xue, Ya-fang Wu, Jin-lan Pan, Juan Shen
Journal: Blood
Blood (2005) 106 (11): 4482.
https://doi.org/10.1182/blood.V106.11.4482.4482
Published: 2005
Journal Articles

Dicentric(7;9)(p11;p11) in Acute Lymphoblastic Leukemia: A Clinical and Laboratory Study of 7 Cases.

Jin-lan Pan, Yong-quan Xue, Ya-fang Wu, Yong Wang, Juan Shen
Journal: Blood
Blood (2005) 106 (11): 4333.
https://doi.org/10.1182/blood.V106.11.4333.4333
Published: 2005